Small molecule hormone or hormone-like ligands of integrin αVβ3: implications for cancer cell behavior (Q38128762)

29 August 2017

title

Small molecule hormone or hormone-like ligands of integrin αVβ3: implications for cancer cell behavior (English)

1 reference

29 August 2017

Paul J Davis

1

1 reference

29 August 2017

Shaker A Mousa

2

1 reference

29 August 2017

Vivian Cody

3

1 reference

29 August 2017

Heng-Yuan Tang

4

1 reference

29 August 2017

Hung-Yun Lin

5

1 reference

29 August 2017

publication date

14 August 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

4

1 reference

29 August 2017

issue

6

1 reference

29 August 2017

page(s)

335-342

1 reference

Ligand binding to integrins

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Integrin structure, activation, and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Integrins in Cell Migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Integrins in cancer: biological implications and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Integrin and growth factor receptor alliance in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Integrin and growth factor receptor crosstalk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Membrane receptor for thyroid hormone: physiologic and pharmacologic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Molecular aspects of thyroid hormone actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Molecular mechanisms of actions of formulations of the thyroid hormone analogue, tetrac, on the inflammatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Thyroid hormone-regulated actin polymerization in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Rapid inhibition of thyroxine-induced bone resorption in the rat by an orally active vitronectin receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Nuclear monomeric integrin αv in cancer cells is a coactivator regulated by thyroid hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

L-Thyroxine vs. 3,5,3'-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Regulation of the Na /H Exchanger (NHE1) in Breast Cancer Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Is the Multifunctional Na /H Exchanger Isoform 1 a Potential Therapeutic Target in Cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Metabolic effects of thyroid hormone derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

A role for thyroid hormone in wound healing through keratin gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Crosstalk between integrin αvβ3 and estrogen receptor-α is involved in thyroid hormone-induced proliferation in human lung carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Radiosensitization of GL261 glioma cells by tetraiodothyroacetic acid (tetrac).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Radiosensitization and production of DNA double-strand breaks in U87MG brain tumor cells induced by tetraiodothyroacetic acid (tetrac)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Upregulation of drug transporter expression by osteopontin in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Thyroid hormone regulates the expression and function of P-glycoprotein in Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Therapeutic potential of resveratrol: the in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Seven sirtuins for seven deadly diseases of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

A patent review of sirtuin activators: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Integrin alphaVbeta3 contains a receptor site for resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: An in silico and biochemical approach targeting integrin αvβ3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Androgen-induced human breast cancer cell proliferation is mediated by discrete mechanisms in estrogen receptor-alpha-positive and -negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Plasma membrane estrogen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Membrane-initiated actions of estradiol that regulate reproduction, energy balance and body temperature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Minireview: Recent Advances in Extranuclear Steroid Receptor Actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Membrane progesterone receptor expression in mammalian tissues: a review of regulation and physiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Two pathways of progesterone action in the human endometrium: implications for implantation and contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Dexamethasone-Associated Cross-Linked Actin Network Formation in Human Trabecular Meshwork Cells Involves β3 Integrin Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Integrin α(v)β₃ as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Involvement of alpha(v)beta3 integrins in osteoclast function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Behavior of primary human osteoblasts on trimmed and sandblasted Ti6Al4V surfaces functionalized with integrin αvβ3-selective cyclic RGD peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Cyclic stretch-induced thrombin generation by rat vascular smooth muscle cells is mediated by the integrin αvβ3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Platelet integrins and immunoreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Human platelet aggregation and degranulation is induced in vitro by L-thyroxine, but not by 3,5,3'-triiodo-L-thyronine or diiodothyropropionic acid (DITPA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Comparison of cyclic RGD peptides for αvβ3 integrin detection in a rat model of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Pilot Pharmacokinetic and Dosimetric Studies of18F-FPPRGD2: A PET Radiopharmaceutical Agent for Imaging αvβ3Integrin Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Combined QM/MM Study of Thyroid and Steroid Hormone Analogue Interactions with Integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12672-013-0156-8

Inhibitory effect of epidermal growth factor on resveratrol-induced apoptosis in prostate cancer cells is mediated by protein kinase C-alpha

21 January 2018

1 reference

12 December 2020

Short-term effects of thyroid hormones on the Na/H antiport in L-6 myoblasts: high molecular specificity for 3,3',5-triiodo-L-thyronine

1 reference

12 December 2020

Molecular modeling of the thyroid hormone interactions with alpha v beta 3 integrin

1 reference

12 December 2020

Pro-angiogenesis action of thyroid hormone and analogs in a three-dimensional in vitro microvascular endothelial sprouting model

1 reference

12 December 2020

Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism

1 reference

12 December 2020

Identification and functions of the plasma membrane receptor for thyroid hormone analogues.

1 reference

12 December 2020

Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts.

1 reference

12 December 2020

Topical thyroid hormone accelerates wound healing in mice

1 reference

12 December 2020

Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac).

1 reference

12 December 2020

Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases

1 reference

12 December 2020

Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence

1 reference

12 December 2020

Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line

1 reference

12 December 2020

Rapid nongenomic effects of 3,5,3'-triiodo-L-thyronine on the intracellular pH of L-6 myoblasts are mediated by intracellular calcium mobilization and kinase pathways

1 reference

12 December 2020

Thyroxine-dependent regulation of integrin-laminin interactions in astrocytes

1 reference

12 December 2020

10.1007/S12672-013-0156-8

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1045193310

0 references

1 reference